Southern Miss Fuels Biotech Growth in Mississippi
Southern Miss advances biomaterials research for immune disease treatment with a $2.5M collaboration, boosting Mississippi's biotech.
- Latest
- Trending
Southern Miss advances biomaterials research for immune disease treatment with a $2.5M collaboration, boosting Mississippi's biotech.
Exploring the reasons behind the finance head replacement by Mozambique's president for improved economic strategy.
Ottawa faces a $140M transit shortfall, risking tax hikes. Mayor urges federal and provincial aid for fairness.
Meta's Reality Labs faces budget cuts despite $4.5B losses. Ready at Dawn shut down to align with new financial goals.
Meta closes Ready at Dawn, known for Echo series, amid cuts to Reality Labs. The studio had a rich history ...
Taboola's Q2 earnings reveal a 237% increase in free cash flow, despite a net loss, signaling strong growth and optimistic ...
Wallem Group emphasizes robust shore-based cybersecurity to ensure smooth fleet operations, deploying AI-powered solutions to stay ahead of threats.
"Sempra's Q2 profit surges due to record-high temperatures; clean energy investments and government policies drive future growth prospects."
PLAYSTUDIOS' Q2 2024 results reveal revenue drop but DAU spike to 3.2M. New games launched, cash strong at $106M. Mixed ...
SI-BONE posts a 20% revenue jump to $40M in Q2 2024; U.S. sales excel by 21%. Sets sights on releasing ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.